Associate Professor @GWSMHS. Lynch Lab investigates antibody responses to virus infection and the use of monoclonal antibodies as therapeutics to combat HIV.
Bit of a side project🤷♀️ But congrats to Andrew for getting me to get his second paper out!!
Probiotic Therapy During Vaccination Alters Antibody Response to Simian-Human Immunodeficiency Virus Infection But Not to Commensals https://t.co/ZYjgNEraIF
Congrats Michelle on our new publication!
Antibody and T-cell responses to COVID-19 Vaccination in Common Variable Immunodeficiency and Specific Antibody Deficiency https://t.co/q7MIExqwp4
Characterizing the Relationship Between Neutralization Sensitivity and env Gene Diversity During ART Suppression https://t.co/NsZl507FWs
Congratulations Andrew - first graduate student publication😍🎉
What are the selective pressures on HIV longitudinally during the course of infection? Elegant paper from B Hahn and K Bar demonstrating type 1 IFNs' restriction on virus after transmission and during virus rebound after analytical treatment interruption
https://t.co/BCcjb5qgQk
Important paper in @NEJM describing clinical data on which HIV strains can be prevented from transmitting when an antibody is used as a prevention method. Unsurprising but moving the antibody field forward!
https://t.co/RVRBtYrwR9
Efficacy of a Broadly Neutralizing SARS-CoV-2 Ferritin Nanoparticle Vaccine in Nonhuman Primates https://t.co/H5mWdpYquz @MHRPInfo@wrair@HJFMilMed @kanekiyom
Check out our newest paper! We are excited to share our findings in @NatureComms on HIV-1 reservoir diversity quantification using the Intact Proviral DNA Assay (IPDA).
https://t.co/bOnyD6rNXi
@hjf@wrair @armyfutures @ccp4_mx@NIH
Structural Biology at EIDB/WRAIR is hiring for a lab manager and two postdoctoral fellows to work on COVID-19 and Emerging Infectious Diseases leveraging structural biology to develop novel vaccines and therapeutics. https://t.co/VBCGzY6dOz
Congratulations Andrew on your first review paper!
Embracing diversity: how can broadly neutralizing antibodies effectively target a diverse HIV-1... - https://t.co/iTi8w5Gz7p #ScholarAlerts